Search This Blog

Monday, December 2, 2019

PDS Bio up 16% ahead of Versamune presentation

Thinly traded nano cap PDS Biotechnology (PDSB +15.5%) is up on modestly higher volume, 100K shares, on no particular news.
On Wednesday, December 4, CMO Lauren Wood, M.D. will deliver a presentation on cancer immunotherapy platform Versamune at the World Vaccine & Immunotherapy Congress West Coast in San Francisco at 3 pm PT.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.